Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
Oncology|January 21, 2020
Interleukin-6: A Masterplayer in the Cytokine NetworkPeter Uciechowski, Wolfram C M DempkeOncology|June 21, 2018
Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?Wolfram C M Dempke, Peter Uciechowski, Klaus Fenchel, et al.Oncology|July 25, 2017
Targeting Developmental Pathways: The Achilles Heel of Cancer?Wolfram C M Dempke, Klaus Fenchel, Peter Uciechowski, et al.European Journal of Cancer (Oxford, England : 1990)|March 25, 2017
Second- and third-generation drugs for immuno-oncology treatment-The more the better?Wolfram C M Dempke, Klaus Fenchel, Peter Uciechowski, et al.Translational Lung Cancer Research|March 26, 2015
Gefitinib in non-small-cell lung cancer-an old lesson new re-visitedWolfram C M DempkeAnticancer Research|December 1, 2010
Brivanib, a novel dual VEGF-R2/bFGF-R inhibitorWolfram C M Dempke, Roland ZippelAnticancer Research|May 18, 2012
Multiple myeloma: myeloablative therapy with autologous stem cell support versus chemotherapy: a meta-analysisFlorian Faussner, Wolfram C M DempkeTranslational Cancer Research|December 19, 2024
Targeting C797S mutations and beyond in non-small cell lung cancer-a mini-reviewWolfram C M Dempke, Klaus FenchelTranslational Lung Cancer Research|July 23, 2021
Has programmed cell death ligand-1 <i>MET</i> an accomplice in non-small cell lung cancer?-a narrative reviewWolfram C M Dempke, Klaus FenchelPageof 6